CareRx Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CAD 93.76 million compared to CAD 97.35 million a year ago. Net loss was CAD 1.44 million compared to CAD 1.78 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.04 a year ago.
For the nine months, sales was CAD 279.65 million compared to CAD 287.41 million a year ago. Net loss was CAD 1.71 million compared to CAD 29.67 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.63 a year ago.